Financial Performance - The company's revenue for Q3 2024 was ¥314,318,633.69, representing a 2.54% increase year-over-year[2] - Net profit attributable to shareholders for Q3 2024 was ¥31,099,762.48, a slight increase of 0.23% compared to the same period last year[2] - The net profit after deducting non-recurring gains and losses for Q3 2024 was ¥27,404,785.61, showing a decrease of 12.33% year-over-year[2] - Total operating revenue for Q3 2024 reached ¥915,266,819.34, a slight increase from ¥905,423,793.77 in Q3 2023, representing a growth of approximately 1.9%[18] - Operating profit for Q3 2024 was ¥103,858,040.01, down from ¥122,151,644.01 in the same period last year, indicating a decrease of about 15%[19] - Net profit for Q3 2024 was ¥82,799,233.94, compared to ¥99,688,950.56 in Q3 2023, reflecting a decline of approximately 16.9%[19] - Basic earnings per share for Q3 2024 were ¥0.48, down from ¥0.57 in Q3 2023, indicating a decrease of approximately 15.8%[20] - Other comprehensive income after tax for Q3 2024 was -¥228,217.17, compared to ¥3,239,930.72 in Q3 2023, indicating a significant decline[20] Assets and Liabilities - Total assets as of September 30, 2024, reached ¥1,284,443,916.97, reflecting a 14.50% increase from the end of the previous year[2] - The total liabilities increased to ¥483,890,002.54 in Q3 2024 from ¥309,486,440.76 in Q3 2023, marking an increase of about 56.3%[18] - Current assets totaled RMB 833,010,196.38, up from RMB 576,920,207.24, marking an increase of approximately 44.4%[17] - Non-current assets decreased to RMB 451,433,720.59 from RMB 544,854,867.37, a decline of about 17.1%[17] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥225,458,103.93, down 9.90% compared to the same period last year[2] - Cash flow from operating activities for Q3 2024 was ¥933,226,854.92, up from ¥917,527,325.91 in Q3 2023, showing a growth of approximately 1.7%[21] - The company reported a net cash flow from operating activities of CNY 225.46 million, down from CNY 250.24 million, a decrease of 9.9%[22] - Net cash outflow from investing activities was CNY 226.23 million, worsening from a net outflow of CNY 157.04 million year-over-year[22] - Cash inflow from investment activities totaled CNY 590.12 million, significantly higher than CNY 103.02 million in the same period last year, indicating a growth of 471.5%[22] - Cash outflow for purchasing fixed assets and intangible assets was CNY 797.66 million, up from CNY 246.40 million, representing an increase of 223.5%[22] - Net cash flow from financing activities was negative at CNY 109.44 million, an improvement from a net outflow of CNY 130.12 million in the previous year[22] - The ending balance of cash and cash equivalents was CNY 81.38 million, a decrease from CNY 191.70 million year-over-year[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 21,922[10] - Louisa Fan holds 21.92% of shares, totaling 38,420,935 shares[10] - Alexander Liu holds 20.25% of shares, totaling 35,491,665 shares[10] - The total number of restricted shares at the beginning of the period was 58,718,368, with 2,325,954 shares released during the period[12] - The company has a total of 56,548,114 restricted shares remaining at the end of the period[12] - The company’s major shareholders, Louisa Fan and Alexander Liu, are identified as the actual controllers of the company[11] - The company has not reported any changes in the top 10 shareholders due to securities lending or borrowing[11] - The company has not disclosed any related party transactions among other shareholders[11] Dividends - The company approved a cash dividend of RMB 1.60 per 10 shares for the 2024 interim profit distribution, with the record date set for October 14, 2024[14] Inventory and Receivables - Inventory as of September 30, 2024, was ¥234,274,900, an increase of 34.32% from the end of the previous year, primarily due to preemptive stocking[6] - Accounts receivable rose to RMB 74,182,632.26 from RMB 64,348,941.76, indicating an increase of about 15%[16] - Other receivables increased to RMB 69,073,452.53 from RMB 51,611,965.06, showing a rise of about 33.8%[17] Legal Matters - The company is actively pursuing legal action to protect its trademark rights, which is expected to have no significant adverse impact on operations[15] - The company has initiated administrative litigation regarding the trademark disputes, with the court already reviewing the case[15] Accounting Standards - The company did not undergo an audit for the third quarter report[23] - The company will implement new accounting standards starting in 2024, affecting the financial statements[23]

证券代码：300622 证券简称：博士眼镜 编号：2024-12 博士眼镜连锁股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | --- | |-----------------------|-------|---------------------------------------------------|------------|----------------------------------------------------------| | | □ | 特定对象调研 | □ | 分析师会议 | | 投资者关系活动 | □ | 媒体采访 | □ | 业绩说明会 | | 类别 | □ | 新闻发布会 □ | | 路演活动 | | | ☑ | 现场参观 | | | | | □ | 其他 | | | | 参与单位名称 | | 金、时代伯乐（排名不分先后） | | 华创证券、信达澳亚、河床资本、东莞资管、中山资管、金信基 | | | | | | | | | | | | | | 时间 | 2024 | 年 10 月 24 日 | | | | 地点 | | 公司会议室 | ...

证券代码：300622 证券简称：博士眼镜 公告编号：2024-071 博士眼镜连锁股份有限公司 2024 年半年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 每股分红金额不变的原则对分红总额进行调整。 特别提示： 1、博士眼镜连锁股份有限公司（以下简称"公司"或"本公司"）2024 年 半年度权益分派方案为：公司以实施权益分派登记日登记的股份总数为基数，向 全体股东每 10 股派发现金股利人民币 1.60 元（含税），不送红股，不以资本公 积金转增股本。截至本公告披露日，公司总股本为 175,260,670 股，按照每股分 红金额不变的原则，预计派发现金红利 28,041,707.20 元（含税）。 2、本次权益分派实施后除权除息参考价=股权登记日收盘价-每股现金红利 =股权登记日收盘价-0.16 元/股。 1、公司于 2024 年 5 月 22 日召开 2023 年度股东大会审议通过了《关于提请 股东大会授权董事会决定 2024 年中期或春节前利润分配的议案》，授权董事会 全权办理 2024 年中期（包含半年度、前三季度）或春节前利润 ...

证券代码：300622 证券简称：博士眼镜 公告编号：2024-069 博士眼镜连锁股份有限公司 2024 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会没有否决或变更议案的情况发生； 2、本次股东大会不涉及变更前次股东大会决议。 一、会议召开和出席情况 （一）会议召开情况 7、本次股东大会的召集、召开符合《中华人民共和国公司法》《上市公司 股东大会规则》《深圳证券交易所创业板股票上市规则》等法律法规、规范性文 件及《博士眼镜连锁股份有限公司章程》的相关规定。 （二）会议出席情况 1、博士眼镜连锁股份有限公司（以下简称"公司"）于 2024 年 8 月 27 日 召开第五届董事会第五次会议审议通过了《关于召开 2024 年第二次临时股东大 会的议案》，通知内容详见 2024 年 8 月 29 日公司披露于巨潮资讯网 （www.cninfo.com.cn）的《博士眼镜连锁股份有限公司关于召开公司 2024 年第 二次临时股东大会的通知》（公告编号：2024-067）。 2、会议召开时间： （1）现场会议 ...

债权人如果提出要求公司清偿债务的，应根据《中华人民共和国公司法》等相 关法律法规的规定，向公司提出书面请求，并随附相关证明文件。 特此公告。 1 博士眼镜连锁股份有限公司 董事会 证券代码：300622 证券简称：博士眼镜 公告编号：2024-070 博士眼镜连锁股份有限公司 关于回购注销部分限制性股票的减资公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 博士眼镜连锁股份有限公司（以下简称"公司"）于 2024 年 7 月 5 日召开第五 届董事会第四次会议、2024 年 9 月 20 日召开 2024 年第二次临时股东大会，审议 通过了《关于调整 2021 年限制性股票与股票期权激励计划限制性股票回购价格及 回购注销部分限制性股票的议案》。鉴于限制性股票 2 名激励对象个人层面绩效考 核结果仅达到部分解除限售条件，公司回购注销上述 2 名激励对象已获授但尚未解 除限售的7,200 股限制性股票。回购注销完成后，公司注册资本相应减少7,200 元， 总股本相应减少 7,200 股。具体内容详见 2024 年 7 月 6 日公司披露于巨潮资讯网 （www. ...

北京│上海│深圳│杭州│广州│昆明│天津│成都│宁波│福州│西安│南京│南宁│济南│重庆│苏州│长沙│太原│武汉│贵阳│乌鲁木齐│郑州│石家庄│合肥│海南│青岛│拉孜 │香港│巴黎│马德里│斯德哥尔摩│纽约 BEIJING │SHANGHAI │SHENZHEN│HANGZHOU │GUANGZHOU│KUNMING │TIANJIN│CHENGDU│NINGBO │FUZHOU │XI'AN │NANJING│NANNING│JINAN│CHONGQING│SUZHOU│CHANGSHA│ 国浩律师（深圳）事务所 关于博士眼镜连锁股份有限公司 TAIYUAN│ WUHAN│GUIYANG│URUMQI│ZHENGZHOU│SHIJIAZHUANG│HEFEI│HAINAN│QINGDAO│LAZI│ HONG KONG│ PARIS│MADRID│STOCKHOLM│NEW YORK 博士眼镜 2024 年第二次临时股东大会法律意见书 实进行了核查和验证，现根据本所律师对事实的了解及对法律的理解，出具法律 意见如下： GLG/SZ/A2426/FY/2024-947 致：博士眼镜连锁股份有限公司 国浩律师（ ...

政旦志远（深圳）会计师事务所（特殊普通合伙）成立日期为 2005 年 1 月 12 日，注册地址为深圳市福田区莲花街道福新社区鹏程一路 9 号广电金融中心 14F，执行事务合伙人为张建栋。更名后，原"深圳大华国际会计师事务所（特 殊普通合伙）"的各项业务、权利和义务由"政旦志远（深圳）会计师事务所（特 殊普通合伙）"承继。 因此，公司 2024 年度财务审计机构名称变更为"政旦志远（深圳）会计师 事务所（特殊普通合伙）"。本次会计师事务所变更事项仅为名称变更，不涉及 主体资格变更，不属于更换或重新聘任会计师事务所事项。 特此公告。 证券代码：300622 证券简称：博士眼镜 公告编号：2024-068 博士眼镜连锁股份有限公司 关于会计师事务所更名的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 博士眼镜连锁股份有限公司（以下简称"公司"）于 2024 年 5 月 22 日召开 了 2023 年度股东大会，审议通过了《关于拟聘任会计师事务所的议案》，同意 聘任深圳大华国际会计师事务所（特殊普通合伙）为公司 2024 年度财务审计机 构。 公司于近日收到深 ...

Investment Rating - The report maintains a "Buy" rating for the company, with projected net profits of 140 million, 170 million, and 200 million yuan for 2024-2026, corresponding to P/E ratios of 34.3X, 28.5X, and 24.8X respectively [1] Core Views - The AR glasses market is experiencing rapid growth, with global and Chinese AR device shipments reaching 510,000 and 200,000 units in 2023, up 37.8% and 53.9% YoY respectively [1] - The company has a significant channel advantage, with a nationwide network of stores and partnerships with major AR players like Huawei, Rokid, and Thunderbird [1] - Customization capabilities in lenses are becoming a key competitive factor, with strong demand for digital, photochromic, and youth myopia control lenses [1] Industry Overview - The AR glasses market is highly concentrated, with the top 5 players accounting for 89.9% of the Chinese market in 2023 [1] - XREAL leads the global consumer AR market with an 81% share in H1 2022 [1] - The global AR device market is expected to reach 5 million units by 2027, with a CAGR of 77.0% from 2023-2027 [14] Company Strategy - The company is strengthening its position in the smart glasses sector through strategic investments and joint ventures, such as the planned collaboration with Thunderbird to develop a domestic version of Meta Ray-Ban [1] - It has established partnerships with multiple AR players, providing online prescription services and offline channel networks [1] - The company is expanding its retail network, with 515 stores nationwide as of 2023, including 495 directly operated stores [28] Financial Performance - Revenue is projected to grow from 1.176 billion yuan in 2023 to 1.771 billion yuan in 2026, with a CAGR of 14.6% [2] - Net profit attributable to shareholders is expected to increase from 128 million yuan in 2023 to 195 million yuan in 2026 [2] - The company's ROE is forecast to rise from 16.2% in 2023 to 18.5% in 2026 [2] Market Opportunities - The myopia control lens market in China is expected to exceed 30 million units by 2030, with a penetration rate of 30% and a market size of over 60 billion yuan [34] - The presbyopia lens market is driven by aging population and consumption upgrade trends, with annual demand of approximately 40 million pairs in China [36] - Emerging applications such as photochromic, night vision, and blue light blocking lenses present additional growth opportunities [42]

Investment Rating - The report maintains a "Buy" rating for the company, with projected net profits of 140 million, 170 million, and 200 million yuan for 2024-2026, corresponding to P/E ratios of 34.3X, 28.5X, and 24.8X respectively [1] Core Views - The AR glasses market is experiencing rapid growth, with global and Chinese AR device shipments reaching 510,000 and 200,000 units in 2023, up 37.8% and 53.9% YoY respectively [1] - The company has a significant channel advantage, with a nationwide network of stores and partnerships with major AR players like Huawei, Rokid, and Thunderbird [1] - Customization capabilities in lenses are becoming a key differentiator, with strong demand for digital, photochromic, and youth myopia control lenses [1] Market and Industry Analysis - The global AR device market is highly concentrated, with the top 5 players accounting for 89.9% of the Chinese market in 2023 and 55.7% globally in 2022 [1] - XREAL leads the global consumer AR market with an 81% share in H1 2022, while Thunderbird Innovation dominates the Chinese market with a 39.1% share in 2023 [1][17] - The AR industry is transitioning from B2B to B2C, with consumer sales accounting for 78.4% of the market in 2023 [1][14] Company Strategy and Positioning - The company is strengthening its position in the smart glasses sector through strategic investments and joint ventures, including a partnership with Thunderbird to develop a domestic version of Meta Ray-Ban [1] - It has established a comprehensive retail network across 23 provinces, leveraging partnerships with malls, supermarkets, and hospitals to enhance its channel capabilities [1] - The company is focusing on the integration of online and offline services, with a strong presence in both physical stores and e-commerce platforms [1] Financial Performance and Projections - Revenue is expected to grow from 1.176 billion yuan in 2023 to 1.771 billion yuan in 2026, with a CAGR of 14.6% [2] - Net profit attributable to shareholders is projected to increase from 128 million yuan in 2023 to 195 million yuan in 2026, with a CAGR of 15.1% [2] - The company's ROE is forecasted to rise from 16.2% in 2023 to 18.5% in 2026, indicating improving profitability [2] Product and Technology Trends - The AR glasses market is shifting towards lighter, more consumer-friendly designs, with magnetic/insertable myopia lenses becoming the mainstream [24] - Pre-installed prescription lenses are emerging as a key area of innovation, with companies like Apple and Meta investing heavily in this technology [24] - The company is actively participating in the development of advanced AR technologies, including partnerships for the production of customized lenses [24] Growth Opportunities - The myopia control market presents significant growth potential, with the penetration rate of defocus lenses expected to increase from 3.5% in 2021 to 30% by 2030 [33] - The aging population and rising consumer demand for premium products are driving growth in the presbyopia lens market, which currently accounts for only 1.5% of the total eyewear market [36] - Emerging applications such as photochromic, night vision, and anti-blue light lenses are creating new opportunities for companies with strong customization capabilities [42]

Investment Rating - The report maintains a "Buy" rating for the company [3] Core Views - The company reported stable operations with a breakthrough in smart glasses, achieving revenue of 601 million yuan in H1 2024, a year-on-year increase of 0.3%, while net profit attributable to shareholders was 52 million yuan, a decrease of 21.3% [1] - The growth rate of optical glasses and fitting services has slowed, but the company is steadily expanding its direct and franchise stores, with a total of 501 direct stores and 29 franchise stores as of the end of Q2 2024 [1] - The company is enhancing its digital retail system and steadily advancing its franchise model, with a significant increase in the sales proportion of functional lenses [1] - The company is exploring the smart glasses sector, establishing stable partnerships with leading brands and planning to develop new products [1] Financial Summary - For H1 2024, the company achieved revenues of 385 million yuan from optical glasses, 107 million yuan from fitting services, and 80 million yuan from contact lenses, with respective year-on-year growth rates of -2.4%, +7.8%, and +3.6% [1] - The company expects net profits for 2024, 2025, and 2026 to be 140 million yuan, 170 million yuan, and 195 million yuan, respectively, with corresponding P/E ratios of 34X, 28X, and 25X [1][2] - The company’s revenue is projected to grow from 1.321 billion yuan in 2024 to 1.771 billion yuan in 2026, with year-on-year growth rates of 12.3% and 15.4% [2][8]